TNFSF14 and metabolic dysfunction-associated steatotic liver disease: In clinical situations, the enhanced expression of LIGHT in serum of patients with nonalcoholic fatty liver disease, asthma, and diabetes has been detectable [5, 25, 26], which indicates that LIGHT has pathogenic effects in various inflammatory diseases.